Trial
NCT01135199
Pomalidomide for Cough in Patients With Idiopathic Pulmonary Fibrosis
Phase IIWITHDRAWNSAFETYConfidence: MEDIUM
Sponsor
Stanford University
Collaborators
Celgene Corporation
Condition
Pulmonary Fibrosis
Intervention
pomalidomide (CC-4047
Why stopped
FDA did not accept sponsor's animal toxicology data to support proposed dosing.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-11-30